Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 130
of 7Next
2:

Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells.

Chen P, Wang J, Hope K, Jin L, Dick J, Cameron R, Brandwein J, Minden M, Reilly RM.

J Nucl Med. 2006 May;47(5):827-36.

PMID: 16644753 [PubMed - indexed for MEDLINE]

3:

Novel ligands for cancer diagnosis: selection of peptide ligands for identification and isolation of B-cell lymphomas.

McGuire MJ, Samli KN, Chang YC, Brown KC.

Exp Hematol. 2006 Apr;34(4):443-52.

PMID: 16569591 [PubMed - indexed for MEDLINE]

4:

Ex-vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.

Rezvani K, Yong AS, Tawab A, Jafarpour B, Eniafe R, Mielke S, Savani BN, Keyvanfar K, Li Y, Kurlander R, Barrett AJ.

Blood. 2008 Nov 6. [Epub ahead of print]

PMID: 18988867 [PubMed - as supplied by publisher]

5:

Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison.

Boehrer S, Adès L, Galluzzi L, Tajeddine N, Tailler M, Gardin C, de Botton S, Fenaux P, Kroemer G.

Biochem Pharmacol. 2008 Dec 1;76(11):1417-25. Epub 2008 Jul 9.

PMID: 18617157 [PubMed - in process]

6:

Constitutively active SHP2 cooperates with HoxA10-overexpression to induce acute myeloid leukemia.

Wang H, Lindsey S, Konieczna I, Bei L, Horvath E, Huang W, Saberwal G, Eklund EA.

J Biol Chem. 2008 Nov 19. [Epub ahead of print]

PMID: 19022774 [PubMed - as supplied by publisher]

7:

Identification of 6-benzylthioinosine as a myeloid leukemia differentiation-inducing compound.

Wald DN, Vermaat HM, Zang S, Lavik A, Kang Z, Peleg G, Gerson SL, Bunting KD, Agarwal ML, Roth BL, Tse W.

Cancer Res. 2008 Jun 1;68(11):4369-76.

PMID: 18519698 [PubMed - indexed for MEDLINE]

8:

Cell viability of acute myeloid leukaemia blasts in culture correlates with treatment outcome.

Maha A, Cheong SK, Leong CF, Seow HF.

Hematology. 2008 Feb;13(1):13-20.

PMID: 18534060 [PubMed - indexed for MEDLINE]

9:

[Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia]

Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.

Zhonghua Xue Ye Xue Za Zhi. 2007 Nov;28(11):731-6. Chinese.

PMID: 18457262 [PubMed - in process]

10:

Defective in vitro growth of primitive hematopoietic cells from pediatric patients with acute myeloid leukemia.

Dorantes-Acosta E, Chávez-González A, Santos JI, Medina-Sanson A, Mayani H.

Pediatr Blood Cancer. 2008 Dec;51(6):741-6.

PMID: 18680148 [PubMed - indexed for MEDLINE]

11:

Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.

Fiskus W, Rao R, Fernandez P, Herger B, Yang Y, Chen J, Kolhe R, Mandawat A, Wang Y, Joshi R, Eaton K, Lee P, Atadja P, Peiper S, Bhalla K.

Blood. 2008 Oct 1;112(7):2896-905. Epub 2008 Jul 25.

PMID: 18660379 [PubMed - indexed for MEDLINE]

12:

[cAMP analogue 8-CPT-cAMP inducing differentiation in the M2b subtype of acute myeloid leukemia cell line Kasumi-1]

Zhu Q, Hu JP, Jia PM, Wang ZY, Tong JH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):44-7. Chinese.

PMID: 18315898 [PubMed - in process]

14:

RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia.

Kim WI, Matise I, Diers MD, Largaespada DA.

Blood. 2008 Oct 24. [Epub ahead of print]

PMID: 18952898 [PubMed - as supplied by publisher]

15:

Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences.

Kersemans V, Cornelissen B, Minden MD, Brandwein J, Reilly RM.

J Nucl Med. 2008 Sep;49(9):1546-54. Epub 2008 Aug 14.

PMID: 18703602 [PubMed - indexed for MEDLINE]

16:

Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.

Shabtay A, Sharabani H, Barvish Z, Kafka M, Amichay D, Levy J, Sharoni Y, Uskokovic MR, Studzinski GP, Danilenko M.

Oncology. 2008;75(3-4):203-14. Epub 2008 Oct 14.

PMID: 18852491 [PubMed - indexed for MEDLINE]

17:

Antitumor activity of bortezomib alone and in combination with TRAIL in human acute myeloid leukemia.

Conticello C, Adamo L, Vicari L, Giuffrida R, Iannolo G, Anastasi G, Caruso L, Moschetti G, Cupri A, Palumbo GA, Gulisano M, De Maria R, Giustolisi R, Di Raimondo F.

Acta Haematol. 2008;120(1):19-30. Epub 2008 Aug 21.

PMID: 18716397 [PubMed - indexed for MEDLINE]

18:

A peptide-based carrier for intracellular delivery of proteins into malignant glial cells in vitro.

Wu C, Lo SL, Boulaire J, Hong ML, Beh HM, Leung DS, Wang S.

J Control Release. 2008 Sep 10;130(2):140-5. Epub 2008 May 24.

PMID: 18632177 [PubMed - indexed for MEDLINE]

19:

Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells.

Nishimura S, Takahashi S, Kamikatahira H, Kuroki Y, Jaalouk DE, O'Brien S, Koivunen E, Arap W, Pasqualini R, Nakayama H, Kuniyasu A.

J Biol Chem. 2008 Apr 25;283(17):11752-62. Epub 2008 Feb 21.

PMID: 18292083 [PubMed - indexed for MEDLINE]

20:

Identification of antiviral mimetic peptides with interferon alpha-2b-like activity from a random peptide library using a novel functional biopanning method.

Zhang Q, Bai G, Chen JQ, Tian W, Cao Y, Pan PW, Wang C.

Acta Pharmacol Sin. 2008 May;29(5):634-40.

PMID: 18430373 [PubMed - in process]

Items 1 - 20 of 130
of 7Next